PMID: 16272755Nov 8, 2005

Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus

Drug Metabolism and Pharmacokinetics
Akiko Matsui-SakataYasufumi Sawada

Abstract

Among various adverse reactions of atypical antipsychotics, weight gain and impaired glucose tolerance are clinically significant. The aim of this study is to analyze quantitatively the contributions of various receptors to these antipsychotics-induced adverse reactions based on the receptor occupancy theory. Two indices of antipsychotics-induced weight gain (the values estimated by a meta-analysis and the observed values in clinical trials) and the morbidity rate of type 2 diabetes mellitus during treatment with antipsychotics were taken from the literature. We calculated the estimated mean receptor occupancies of alpha1 adrenergic, alpha2 adrenergic, dopamine D2, histamine H1, muscarinic acetylcholine (mACh), serotonin 5-HT1A, 5-HT2A and 5-HT2C receptors by antipsychotics by using the pharmacokinetic parameters and receptor dissociation constants, and analyzed the correlation between the occupancies and the extent of adverse reactions as assessed using the aforementioned indices. There were statistically significant correlations between the estimated occupancies of H1 and mACh receptors and antipsychotics-induced weight gain estimated by meta-analysis (r(s) = 0.81 and r(s) = 0.83, respectively, p < 0.01). There were also stat...Continue Reading

References

Apr 1, 1977·Clinical Pharmacology and Therapeutics·S G Dahl, R E Strandjord
Mar 1, 1991·Pharmacology, Biochemistry, and Behavior·S Q Luo, E T Li
Aug 2, 1985·The Medical Letter on Drugs and Therapeutics
Feb 1, 1986·The British Journal of Psychiatry : the Journal of Mental Science·J KrskaS D Soni
Nov 10, 1987·European Journal of Pharmacology·T J WanderE Richelson
Dec 1, 1987·Journal of Clinical Psychopharmacology·J ClaghornG Klerman
Oct 1, 1987·Pharmaceutical Research·M G ChocJ Volavka
Jan 1, 1968·The American Journal of Psychiatry·E Thonnard-Neumann
Aug 17, 1984·European Journal of Pharmacology·E Richelson, A Nelson
Dec 1, 1984·Neuropharmacology·J E Blundell
Jan 1, 1984·European Archives of Psychiatry and Neurological Sciences·P LinkowskiJ Mendlewicz
Jan 1, 1983·European Journal of Clinical Pharmacology·K K MidhaK Hall
Jan 1, 1981·European Journal of Clinical Pharmacology·G NybergE Mårtensson
Jan 1, 1995·Schizophrenia Bulletin·J M Stanton
May 1, 1994·Psychopharmacology·G MannensJ Heykants
Aug 1, 1994·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·D D MillerN C Andreasen
Nov 1, 1995·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M AravagiriR J Baldessarini
May 1, 1996·The British Journal of Psychiatry. Supplement·S R HirschL A Arvanitis
Feb 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C M BeasleyS H Hamilton
Nov 12, 1996·Proceedings of the National Academy of Sciences of the United States of America·I InoueT Watanabe
Feb 1, 1997·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Y SawadaTatsuji Iga
May 1, 1997·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·C M BeasleyJ N Beuzen
Aug 1, 1997·Clinical Pharmacology and Therapeutics·S L WongG R Granneman
Nov 14, 1997·Acta Psychiatrica Scandinavica·J Peuskens, C G Link
Nov 3, 1998·Biological Psychiatry·D A WirshingW C Wirshing
Dec 2, 1998·British Journal of Clinical Pharmacology·G SchaberU Breyer-Pfaff
Apr 8, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·D G DanielM Lakshminarayanan
Jun 18, 1999·The Journal of Clinical Psychiatry·D Naber
Dec 22, 1999·Physiology & Behavior·T MorimotoA Yamatodani
Jan 11, 2000·Clinical Pharmacokinetics·S Kudo, T Ishizaki
Aug 6, 2000·The Annals of Pharmacotherapy·T L BettingerM L Crismon
Aug 22, 2001·European Journal of Pharmacology·A W SchmidtS H Zorn
Oct 20, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·A MolletE Scharrer
Nov 28, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Karin HedenmalmOlav Spigset
Mar 12, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Wesley K KroezeBryan L Roth
Mar 26, 2003·Journal of Clinical Epidemiology·John B BuseLois Jovanovic
Apr 30, 2003·Diabetes Care·Michael E J Lean, Frank-Gerald Pajonk
Jan 1, 1958·The Psychiatric Quarterly·K PLANANSKY

Citations

Feb 13, 2009·Der Nervenarzt·Daniel J MüllerA Heinz
Aug 19, 2009·Psychopharmacology·Shona L KirkGavin P Reynolds
Jan 25, 2013·Psychopharmacology·Melanie GuenetteGary Remington
Nov 19, 2013·Clinical Drug Investigation·Alfonso Rodríguez-Martínez, Carlos Guzmán Quilo
Mar 3, 2010·Molecular Psychiatry·D E AdkinsE J C G van den Oord
Nov 30, 2011·The Journal of Biological Chemistry·Hao WangGuoqing Sheng
May 19, 2011·Clinical Neuropharmacology·Francisco López-Muñoz, Cecilio Álamo
May 30, 2009·Diabetes, Obesity & Metabolism·Richard I G Holt, Robert C Peveler
Sep 16, 2010·BMC Psychiatry·Michael CaseVicki Poole Hoffmann
Aug 30, 2008·Neuropsychiatric Disease and Treatment·Jeffrey R Bishop, Mani N Pavuluri
Dec 3, 2011·CNS Drugs·James L RoerigJames E Mitchell
Jul 20, 2012·Experimental & Molecular Medicine·Jee-Eun OhOh-Joo Kwon
Aug 17, 2011·Pharmacogenomics·Arne J RisseladaToine C G Egberts
Jan 1, 2011·Schizophrenia Research and Treatment·Fabio PanarielloAndrea de Bartolomeis
Sep 20, 2006·Pharmacogenomics·Daniel J Müller, James L Kennedy
Feb 20, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Jiamei LianChao Deng
Jun 6, 2009·Issues in Mental Health Nursing·Mary Ann Nemcek, Elizabeth N Austin
May 9, 2012·Expert Opinion on Drug Safety·Juan A GallegoChristoph U Correll
Aug 1, 2009·Expert Opinion on Drug Discovery·Gianluca NucciItalo Poggesi
Nov 6, 2008·Expert Opinion on Drug Safety·Joshua T Kantrowitz, Leslie Citrome
Sep 10, 2013·Endocrinology and Metabolism Clinics of North America·Chao Deng
Dec 14, 2012·Pharmacology, Biochemistry, and Behavior·Steve MannGary Remington
Oct 11, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·K Weston-GreenChao Deng
Dec 15, 2010·Thérapie·Leila ChebaneCentres Régionaux de Pharmacovigilance Français
Aug 18, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Chang-Hua HuQing Wang
Dec 1, 2009·The Psychiatric Clinics of North America·Palmiero MonteleoneMario Maj
Nov 26, 2009·Pharmacology & Therapeutics·Gavin P Reynolds, Shona L Kirk
Nov 20, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Chao DengX-F Huang
Mar 13, 2014·Harvard Review of Psychiatry·Carol CurtinLinda G Bandini
Mar 25, 2009·Pharmacology & Therapeutics·Sarah Grimwood, Paul R Hartig
Jun 17, 2008·Journal of the Neurological Sciences·Oraporn SitburanaWilliam G Ondo
Mar 21, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Chao DengX-F Huang
Sep 5, 2012·Acta Psychiatrica Scandinavica·X FanD C Henderson
Apr 15, 2010·Brain Research·Kent C BerridgeAlexandra G DiFeliceantonio
Aug 11, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·François MontastrucMaryse Lapeyre-Mestre
Sep 5, 2013·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Margaret K HahnAdria Giacca
Mar 19, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Jiamei LianChao Deng
Aug 16, 2011·Progress in Neuro-psychopharmacology & Biological Psychiatry·Andréa L SertiéWagner F Gattaz
Feb 5, 2008·The International Journal of Neuropsychopharmacology·Audun O Vik-MoVidar M Steen
Sep 7, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Virginio SalviFrancesco Barone-Adesi
Nov 30, 2012·Journal of Psychopharmacology·Gavin P Reynolds
Mar 12, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chiaki TanakaHeidi A Lane
Oct 22, 2013·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Ana Maria VolpatoJoão Quevedo
Jan 15, 2008·Journal of Child Neurology·William G OndoAnthony Davis
Dec 7, 2017·Frontiers in Neuroscience·Jiezhong ChenChao Deng
Dec 1, 2011·Therapeutic Advances in Psychopharmacology·Gavin P Reynolds
Jun 30, 2018·Stress and Health : Journal of the International Society for the Investigation of Stress·Joya N HamptonElaine F Walker
Sep 12, 2017·Journal of Psychopharmacology·Gavin P Reynolds, Olga O McGowan
Jan 22, 2008·Journal of Clinical Psychopharmacology·James L RoerigBlake A Gosnell
Jul 16, 2010·Journal of Clinical Psychopharmacology·Chao DengX-F Huang
Nov 26, 2010·Journal of Clinical Psychopharmacology·Arne J RisseladaHans Mulder
Jan 1, 2016·Journal of Neurophysiology·Imran J AnwarAndrea Zsombok
Nov 10, 2017·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·X-F HuangY Yu
Oct 9, 2013·Journal of Clinical Psychopharmacology·Jeffrey S BarrettSteven D Douglas
Apr 24, 2013·Journal of Clinical Psychopharmacology·Beata R GodlewskaJerzy Landowski
Jun 29, 2012·Molecular Biology Reports·Shaona NiuGuoqing Sheng
Aug 4, 2009·Arquivos brasileiros de endocrinologia e metabologia·Cecília AttuxRodrigo A Bressan
May 10, 2017·Drugs & Aging·Bart A A FranxDeborah R Gustafson
Nov 19, 2019·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Mikio SuzukiTakashi Futamura
Jun 3, 2017·Frontiers in Endocrinology·Ryan Michael Cassidy, Qingchun Tong
Aug 28, 2020·Physiology & Behavior·Ileana Morales, Kent C Berridge

Related Concepts

Diabetes Mellitus, Non-Insulin-Dependent
Norepinephrine Receptors
Receptors, Drug
Receptors, Histamine H1
Muscarinic Acetylcholine Receptor
Antipsychotic Effect
Meta Analysis (Statistical Procedure)
Weight Gain
Dopamine D2 Receptor
Receptor, Serotonin,5-HT2C

Related Feeds

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here